No association between opioids, breast cancer recurrence
the ONA take:
There is no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence, a new study published online ahead of print in the journal Cancer has shown.
Because opioids may affect immune function, researchers sought to determine whether postdiagnosis opioid use is associated with breast cancer recurrence. For the retrospective analysis, researchers identified 34,188 patients with incident, early stage breast cancer who were diagnosed between 1996 and 2008 in Denmark.
Results showed that there was no association between ever-use of opioids and breast cancer recurrence. When researchers adjusted for opioid type, strength, duration of use, and cumulative dose, there was still no association.
Researchers found that breast cancer recurrence rates were lower among users of strongly immunosuppressive opioids, but they note that bias could have been a contributing factor.
The findings suggest that opioids, which are frequently use to manage painassociated with comorbid conditions during cancer survivorship, do not increase the risk for developing breast cancer recurrence.
There is no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|